CD73-INHIBITOREN
European patent · EP3787635 · In force
Register entry
- Publication number
- EP3787635
- Application number
- EP19796584
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 30, 2019
- Published
- Mar 10, 2021
- Granted
- Sep 17, 2025
- Protection ends at the latest
- Apr 29, 2039
- Next annual fee due
- Apr 30, 2026
- IPC classes
- A61K 31/662 (2006.01)C07F 9/6561 (2006.01)A61K 45/06 (2006.01)A61K 31/12 (2006.01)A61K 31/10 (2006.01)A61P 25/28 (2006.01)
- Priority
- US 201862664841 P 30.04.2018US 201862737647 P 27.09.2018US 201862757714 P 08.11.2018US 201862777697 P 10.12.2018US 201962810790 P 26.02.2019
- PCT application
- PCT/US2019/030068 30.04.2019
- PCT publication
- WO2019/213174 07.11.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 29, 2026
Change
Published in Swissreg on 29.07.2026
- Sep 17, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 17.09.2025
Parties
Holder
Inventor
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
San Francisco, CA 94080, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.